Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.93 - $2.15 $19,806 - $45,788
-21,297 Reduced 53.33%
18,639 $26,000
Q2 2023

Aug 11, 2023

BUY
$4.67 - $6.55 $52,813 - $74,073
11,309 Added 39.5%
39,936 $191,000
Q4 2022

Aug 11, 2023

SELL
$5.09 - $9.05 $13,676 - $24,317
-2,687 Reduced 8.58%
28,627 $160,000
Q4 2022

Feb 13, 2023

SELL
$5.09 - $9.05 $13,676 - $24,317
-2,687 Reduced 8.58%
28,627 $160,000
Q3 2022

Aug 11, 2023

SELL
$3.5 - $7.2 $4,123 - $8,481
-1,178 Reduced 3.63%
31,314 $201,000
Q3 2022

Nov 03, 2022

SELL
$3.5 - $7.2 $4,123 - $8,481
-1,178 Reduced 3.63%
31,314 $201,000
Q2 2022

Aug 11, 2023

BUY
$2.7 - $7.62 $6,793 - $19,171
2,516 Added 8.39%
32,492 $111,000
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.62 $6,793 - $19,171
2,516 Added 8.39%
32,492 $111,000
Q1 2022

Aug 11, 2023

BUY
$6.3 - $8.84 $8,498 - $11,925
1,349 Added 4.71%
29,976 $213,000
Q1 2022

May 20, 2022

SELL
$6.3 - $8.84 $44,389 - $62,286
-7,046 Reduced 19.03%
29,976 $213,000
Q4 2021

Feb 16, 2022

SELL
$6.02 - $11.43 $5,725 - $10,869
-951 Reduced 2.5%
37,022 $308,000
Q3 2021

Nov 12, 2021

SELL
$5.46 - $22.6 $8,108 - $33,561
-1,485 Reduced 3.76%
37,973 $264,000
Q2 2021

Aug 12, 2021

BUY
$18.46 - $24.36 $147,292 - $194,368
7,979 Added 25.35%
39,458 $941,000
Q1 2021

May 03, 2021

SELL
$17.66 - $28.92 $31,876 - $52,200
-1,805 Reduced 5.42%
31,479 $648,000
Q4 2020

Feb 12, 2021

BUY
$23.25 - $37.73 $62,170 - $100,890
2,674 Added 8.74%
33,284 $815,000
Q3 2020

Nov 09, 2020

BUY
$3.74 - $28.74 $9,170 - $70,470
2,452 Added 8.71%
30,610 $867,000
Q2 2020

Aug 10, 2020

BUY
$3.04 - $6.2 $3,748 - $7,644
1,233 Added 4.58%
28,158 $131,000
Q1 2020

May 15, 2020

BUY
$2.64 - $3.82 $4,757 - $6,883
1,802 Added 7.17%
26,925 $96,000
Q4 2019

Feb 14, 2020

BUY
$2.99 - $4.42 $3,593 - $5,312
1,202 Added 5.02%
25,123 $87,000
Q3 2019

Nov 12, 2019

BUY
$2.29 - $4.16 $54,779 - $99,511
23,921 New
23,921 $94,000
Q3 2018

Nov 14, 2018

SELL
$7.33 - $9.23 $146,182 - $184,073
-19,943 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$6.91 - $9.55 $14,469 - $19,997
2,094 Added 11.73%
19,943 $171,000
Q1 2018

May 15, 2018

BUY
$7.34 - $11.16 $1,247 - $1,897
170 Added 0.96%
17,849 $130,000
Q4 2017

Feb 08, 2018

BUY
$9.15 - $12.64 $5,828 - $8,051
637 Added 3.74%
17,679 $178,000
Q3 2017

Nov 14, 2017

BUY
$12.81 - $16.85 $218,308 - $287,157
17,042
17,042 $273,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.